BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 27606822)

  • 1. Assessment of Nonalcoholic Fatty Liver Disease in Rats Using Quantitative Dynamic Contrast-Enhanced MRI.
    Wu Z; Cheng ZL; Yi ZL; Xie MW; Zeng H; Lu LJ; Xu X; Shen J
    J Magn Reson Imaging; 2017 May; 45(5):1485-1493. PubMed ID: 27606822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
    Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
    J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
    Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
    Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.
    Kim TH; Jun HY; Kim KJ; Lee YH; Lee MS; Choi KH; Yun KJ; Jeong YY; Jun CH; Cho EY; Yoon KH
    J Magn Reson Imaging; 2017 Nov; 46(5):1298-1310. PubMed ID: 28225569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
    Park CC; Nguyen P; Hernandez C; Bettencourt R; Ramirez K; Fortney L; Hooker J; Sy E; Savides MT; Alquiraish MH; Valasek MA; Rizo E; Richards L; Brenner D; Sirlin CB; Loomba R
    Gastroenterology; 2017 Feb; 152(3):598-607.e2. PubMed ID: 27911262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced MRI with Gd-EOB-DTPA for the quantitative assessment of early-stage liver fibrosis induced by carbon tetrachloride in rabbits.
    Liu HF; Wang Q; Du YN; Zhu ZH; Li YF; Zou LQ; Xing W
    Magn Reson Imaging; 2020 Jul; 70():57-63. PubMed ID: 32325235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of liver surface nodularity quantification program and its clinical application in nonalcoholic fatty liver disease.
    Kim TH; Kim JE; Ryu JH; Jeong CW
    Sci Rep; 2019 Jul; 9(1):9994. PubMed ID: 31292497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stratifying Non-alcoholic Steatohepatitis With the Non-invasive Ultrasound Markers Shear Wave Dispersion Slope and Shear Wave Velocity: An Animal Study.
    Kong W; Tang Y; Liu L; Zhang G; Liu Y; Liu J
    Ultrasound Med Biol; 2022 Dec; 48(12):2442-2448. PubMed ID: 36096895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
    Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
    Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease.
    Hayashi T; Saitoh S; Fukuzawa K; Tsuji Y; Takahashi J; Kawamura Y; Akuta N; Kobayashi M; Ikeda K; Fujii T; Miyati T; Kumada H
    Gut Liver; 2017 Sep; 11(5):674-683. PubMed ID: 28651300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of liver fibrosis in rats by MRI with apparent diffusion coefficient and T1 relaxation time in the rotating frame.
    Hu G; Zhang X; Liang W; Zhong X; Chan Q; Lin X; Lin T; Li Y; Quan X
    J Magn Reson Imaging; 2016 May; 43(5):1082-9. PubMed ID: 26497954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Water Specific MRI T1 Mapping for Evaluating Liver Inflammation Activity Grades in Rats With Methionine-Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease.
    Wan Q; Peng H; Lyu J; Liu F; Cheng C; Qiao Y; Deng J; Zheng H; Wang Y; Zou C; Liu X
    J Magn Reson Imaging; 2022 Nov; 56(5):1429-1436. PubMed ID: 35212074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shear Wave Elastography for Assessment of Steatohepatitis and Hepatic Fibrosis in Rat Models of Non-Alcoholic Fatty Liver Disease.
    Kang BK; Lee SS; Cheong H; Hong SM; Jang K; Lee MG
    Ultrasound Med Biol; 2015 Dec; 41(12):3205-15. PubMed ID: 26349582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Multiparametric CT for Identification of High-Risk NAFLD.
    Lubner MG; Graffy PM; Said A; Watson R; Zea R; Malecki KM; Pickhardt PJ
    AJR Am J Roentgenol; 2021 Mar; 216(3):659-668. PubMed ID: 33474981
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study.
    Lemoine M; Assoumou L; De Wit S; Girard PM; Valantin MA; Katlama C; Necsoi C; Campa P; Huefner AD; Schulze Zur Wiesch J; Rougier H; Bastard JP; Stocker H; Mauss S; Serfaty L; Ratziu V; Menu Y; Schlue J; Behrens G; Bedossa P; Capeau J; Ingiliz P; Costagliola D;
    J Acquir Immune Defic Syndr; 2019 Apr; 80(4):e86-e94. PubMed ID: 30570529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity.
    Pavlides M; Banerjee R; Tunnicliffe EM; Kelly C; Collier J; Wang LM; Fleming KA; Cobbold JF; Robson MD; Neubauer S; Barnes E
    Liver Int; 2017 Jul; 37(7):1065-1073. PubMed ID: 27778429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gd-EOB-DTPA-enhanced T1ρ imaging vs diffusion metrics for assessment liver inflammation and early stage fibrosis of nonalcoholic steatohepatitis in rabbits.
    Xie Y; Zhang H; Jin C; Wang X; Wang X; Chen J; Xu Y
    Magn Reson Imaging; 2018 May; 48():34-41. PubMed ID: 29278765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic Steatohepatitis.
    Alsaqal S; Hockings P; Ahlström H; Gummesson A; Hedström A; Hulthe J; Johansson L; Niessen HG; Schoelch C; Schultheis C; Vessby J; Wanders A; Rorsman F; Ebeling Barbier C
    J Magn Reson Imaging; 2022 Aug; 56(2):368-379. PubMed ID: 34953171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver histology and diffusion-weighted MRI in children with nonalcoholic fatty liver disease: A MAGNET study.
    Manning P; Murphy P; Wang K; Hooker J; Wolfson T; Middleton MS; Newton KP; Behling C; Awai HI; Durelle J; Paiz MN; Angeles JE; De La Pena D; McCutchan JA; Schwimmer JB; Sirlin CB
    J Magn Reson Imaging; 2017 Oct; 46(4):1149-1158. PubMed ID: 28225568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis.
    Wildman-Tobriner B; Middleton MM; Moylan CA; Rossi S; Flores O; Chang ZA; Abdelmalek MF; Sirlin CB; Bashir MR
    Gastroenterology; 2018 Nov; 155(5):1428-1435.e2. PubMed ID: 30031769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.